GPR17 antagonists (Omeros)

N/A

Report date: 2025/03/20 15:33:57
NME

Base Information

Drug NameGPR17 antagonists (Omeros)
Drug Alias NameGPR17 antagonists (Omeros/RNI)GPR17 modulators (Omeros)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionG protein-coupled receptor 17 antagonists
TargetsG protein-coupled receptor 17
Therapy Area/IndicationsSpinal Cord InjuriesBrain Injuries, TraumaticMultiple Sclerosis +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOmeros Corp
China Registration ClassN/A

Develop Information

Active CompaniesRenovoOmeros Corp
Inactive CompaniesN/A
Active IndicationsMultiple Sclerosis
Inactive IndicationsSpinal Cord InjuriesBrain Injuries, TraumaticNervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A